Thrivent Financial for Lutherans’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-33,978
| Closed | -$1.11M | – | 2515 |
|
|
2022
Q2 | $1.11M | Buy |
33,978
+6,176
| +22% | +$202K | ﹤0.01% | 1650 |
|
|
2022
Q1 | $731K | Buy |
27,802
+9
| +0% | +$237 | ﹤0.01% | 2008 |
|
|
2021
Q4 | $660K | Buy |
27,793
+205
| +0.7% | +$4.87K | ﹤0.01% | 2081 |
|
|
2021
Q3 | $692K | Sell |
27,588
-271
| -1% | -$6.8K | ﹤0.01% | 2033 |
|
|
2021
Q2 | $724K | Buy |
27,859
+33
| +0.1% | +$858 | ﹤0.01% | 2031 |
|
|
2021
Q1 | $713K | Sell |
27,826
-207
| -0.7% | -$5.3K | ﹤0.01% | 2066 |
|
|
2020
Q4 | $562K | Sell |
28,033
-52
| -0.2% | -$1.04K | ﹤0.01% | 2084 |
|
|
2020
Q3 | $481K | Sell |
28,085
-208
| -0.7% | -$3.56K | ﹤0.01% | 1989 |
|
|
2020
Q2 | $617K | Sell |
28,293
-277
| -1% | -$6.04K | ﹤0.01% | 1810 |
|
|
2020
Q1 | $661K | Buy |
28,570
+1,426
| +5% | +$33K | ﹤0.01% | 1560 |
|
|
2019
Q4 | $895K | Buy |
27,144
+16
| +0.1% | +$528 | ﹤0.01% | 1556 |
|
|
2019
Q3 | $864K | Buy |
27,128
+629
| +2% | +$20K | ﹤0.01% | 1507 |
|
|
2019
Q2 | $681K | Buy |
26,499
+668
| +3% | +$17.2K | ﹤0.01% | 1638 |
|
|
2019
Q1 | $656K | Buy |
25,831
+1,915
| +8% | +$48.6K | ﹤0.01% | 1648 |
|
|
2018
Q4 | $814K | Buy |
23,916
+526
| +2% | +$17.9K | ﹤0.01% | 1292 |
|
|
2018
Q3 | $834K | Buy |
23,390
+431
| +2% | +$15.4K | ﹤0.01% | 1405 |
|
|
2018
Q2 | $792K | Buy |
22,959
+693
| +3% | +$23.9K | ﹤0.01% | 1410 |
|
|
2018
Q1 | $749K | Buy |
22,266
+2,361
| +12% | +$79.4K | ﹤0.01% | 1406 |
|
|
2017
Q4 | $760K | Sell |
19,905
-415
| -2% | -$15.8K | ﹤0.01% | 1416 |
|
|
2017
Q3 | $762K | Buy |
20,320
+340
| +2% | +$12.8K | ﹤0.01% | 1326 |
|
|
2017
Q2 | $745K | Buy |
19,980
+1,410
| +8% | +$52.6K | ﹤0.01% | 1278 |
|
|
2017
Q1 | $729K | Buy |
18,570
+930
| +5% | +$36.5K | ﹤0.01% | 1342 |
|
|
2016
Q4 | $614K | Buy |
17,640
+790
| +5% | +$27.5K | ﹤0.01% | 1406 |
|
|
2016
Q3 | $662K | Buy |
16,850
+750
| +5% | +$29.5K | ﹤0.01% | 1322 |
|
|
2016
Q2 | $609K | Buy |
16,100
+730
| +5% | +$27.6K | ﹤0.01% | 1329 |
|
|
2016
Q1 | $591K | Buy |
15,370
+1,150
| +8% | +$44.2K | ﹤0.01% | 1297 |
|
|
2015
Q4 | $683K | Buy |
14,220
+570
| +4% | +$27.4K | ﹤0.01% | 1216 |
|
|
2015
Q3 | $538K | Buy |
13,650
+850
| +7% | +$33.5K | ﹤0.01% | 1185 |
|
|
2015
Q2 | $545K | Buy |
12,800
+1,000
| +8% | +$42.6K | ﹤0.01% | 1066 |
|
|
2015
Q1 | $466K | Hold |
11,800
| – | – | ﹤0.01% | 1146 |
|
|
2014
Q4 | $425K | Sell |
11,800
-36,922
| -76% | -$1.33M | ﹤0.01% | 1201 |
|
|
2014
Q3 | $1.44M | Buy |
48,722
+1,150
| +2% | +$33.9K | 0.01% | 761 |
|
|
2014
Q2 | $1.2M | Buy |
47,572
+37,422
| +369% | +$941K | 0.01% | 831 |
|
|
2014
Q1 | $262K | Buy |
10,150
+50
| +0.5% | +$1.29K | ﹤0.01% | 1324 |
|
|
2013
Q4 | $227K | Hold |
10,100
| – | – | ﹤0.01% | 1422 |
|
|
2013
Q3 | $143K | Sell |
10,100
-1,000
| -9% | -$14.2K | ﹤0.01% | 1484 |
|
|
2013
Q2 | $152 | Buy |
+11,100
| New | +$152 | ﹤0.01% | 1491 |
|